X
KRYS icon

Xponance’s Krystal Biotech KRYS Stock Holding History

Xponance’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$604K Buy
2,339
+380
+19% +$101K ﹤0.01% 935
2025
Q4 		$483K Buy
1,959
+8
+0.4% +$1.68K ﹤0.01% 966
2025
Q3 		$344K Buy
1,951
+22
+1% +$3.29K ﹤0.01% 1098
2025
Q2 		$265K Buy
1,929
+56
+3% +$8.22K ﹤0.01% 1190
2025
Q1 		$338K Buy
1,873
+88
+5% +$14.8K ﹤0.01% 1058
2024
Q4 		$280K Buy
1,785
+155
+10% +$27.5K ﹤0.01% 1149
2024
Q3 		$297K Buy
1,630
+53
+3% +$10.2K ﹤0.01% 1095
2024
Q2 		$290K Buy
1,577
+265
+20% +$44.5K ﹤0.01% 1068
2024
Q1 		$233K Buy
+1,312
New +$182K ﹤0.01% 1136

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return